Comparison of Intubating Conditions with 0.6 mg/kg and 0.9 mg/kg Rocuronium Bromide for Rapid Sequence Intubation
Journal Title: International Journal of Medical Research & Health Sciences (IJMRHS) - Year 2017, Vol 6, Issue 2
Abstract
Introduction: Dose of rocuronium bromide usually used for rapid sequence intubation (RSI) allows rapid paralysis but the duration of action is prolonged making it unsuitable for short duration surgeries. Theoretically, use of low doses of neuromuscular blocking agents shortens the time for recovery from neuromuscular blockade (NMB). Hence we studied the intubating conditions of rocuronium bromide at 2 × ED95 dose (0.6 mg/kg) in comparison with 3 × ED95 dose (0.9 mg/kg). Methods: Sixty patients aged 18-60 years, ASA PS 1 and 2 posted for elective surgeries requiring GA with endotracheal intubation were studied. Patients were randomized into two groups of 30 each (Group A and B), to receive either 0.6 mg/kg rocuronium bromide or 0.9 mg/kg rocuronium bromide. Intubating condition was assessed at 60 seconds. Onset and clinical duration were recorded and data analysed using independent sample t-test and chi-square analysis. Results: There was a signifcant difference in the intubating conditions between the groups (p=0.001) with 28 patients (93.3%) having excellent intubating conditions and 2 (6.6%) having good intubating conditions in Group B whereas 16 patients (53.3%) had excellent intubating conditions and 12 (40%) had good intubating conditions in Group A. None had inadequate conditions for intubation. There was signifcant difference (p<0.0001) between the mean clinical duration of NMB in group A (29.37 min ± 5.73 min) and Group B (50.10 min ± 6.69 min). Conclusion: We concluded that rocuronium bromide at 0.9 mg/kg provided good to excellent intubating conditions at 60 seconds but at the cost of prolonged duration of NMB. Whereas rocuronium bromide at 0.6 mg/kg provided adequate intubating conditions for RSI at 60 seconds and hence could be used at this dose in situations where succinylcholine is contraindicated and a shorter duration of NMB is preferred.
Authors and Affiliations
Brijesh Savidhan| Department of Anaesthesiology, Travancore Medical College, Kollam, India, Corresponding e-mail: brijesh_savidhan@yahoo.com, Marina Kuruvilla| Department of Anaesthesiology and Critical Care, Lourdes Hospital, Kochi, India, Shobha Philip| Department of Anaesthesiology and Critical Care, Lourdes Hospital, Kochi, India
COST ANALYSIS OF LONG ESTABLISHED AND NEWER ORAL ANTIEPILEPTIC DRUGS AVAILABLE IN THE INDIAN MARKET
Background: Large number of pharmaceutical companies manufactures antiepileptic drugs in India. The price variations among the marketed drugs are wide. Aims: The present study was aimed to find the cost of different or...
Te Burden of Gastroenteritis in the Post-Rotavirus Vaccine Era in Ghana: A Hospital Diagnoses-Based Study
Globally, gastroenteritis is the second cause of post-neonatal morbidity and mortality. Aims: This study evaluates the burden of acute gastroenteritis (AGE) in the central part of the Volta Region of Ghana to assess the...
CARCINOMA CERVIX SCREENING – A CLINICOPATHOLOGICAL STUDY
Background: Cervical carcinoma, the pathogenesis of which includes multiple factors was the leading cause of death 50 years ago and the mortality rate has been reduced to two thirds due to the effective screening by Pap...
The Process of Parents' Decision-Making to Discharge Their Child against Medical Advice (DAMA): A grounded theory study
Discharge against medical advice (DAMA) refers to the phenomenon that patient or the patient’s surrogate decides to leave the hospital before the attending physician confirms the patient is discharged. Children are mu...
Comparison of IL-13 and IL-27 levels between schizophrenics and healthy subjects before and after antipsychotic administration
Many new evidences suggest cytokine activities involvement in pathogenicity of schizophrenia. Therefore, the aim of this study was to assess the serum levels of IL-13 and 27 in schizophrenics, and then compares them wit...